Plasma fibronectin levels during daily plasmapheresis.

Area of Science:

• Biochemistry
• Hematology
• Immunology

Background:

• Multiple myeloma is a hematologic malignancy.
• Plasma fibronectin is a glycoprotein involved in various physiological processes.
• Understanding fibronectin dynamics is crucial in managing hematologic disorders.

Purpose of the Study:

• To investigate the impact of plasma exchange on plasma fibronectin concentrations in multiple myeloma patients.
• To assess the resynthesis rate and recovery of plasma fibronectin levels post-treatment.

Main Methods:

• Studied 10 patients with multiple myeloma.
• Administered plasma exchange (2.5-3 L daily) for 3 days.
• Monitored plasma fibronectin concentrations before, during, and after plasma exchange.

Main Results:

• Plasma fibronectin decreased to approximately 50% of baseline levels after 3 days of plasma exchange.
• Fibronectin resynthesis increased during plasmapheresis, normalizing levels.
• Plasma fibronectin concentrations returned to baseline within 2 days post-cessation, despite concurrent cytotoxic treatment.
• No signs of infection were observed in the studied patients.

Conclusions:

• Plasma exchange effectively reduces plasma fibronectin in multiple myeloma.
• The body demonstrates a rapid capacity for fibronectin resynthesis and recovery.
• Fibronectin levels can normalize quickly after plasma exchange, irrespective of cytotoxic therapy.